Table 1 Baseline characteristics.

From: Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial

 

HBOT

Control

p-value

N

37

36

 

Age (years)

48.4 ± 10.6

47.8 ± 8.5

0.784

Males

18 (48.6)

11 (30.6)

0.153

Female

19 (51.4)

25 (69.4)

0.153

BMI (Kg/m2)

26.9 ± 5.1

26.5 ± 4.7

0.690

Years of education

14.6 ± 2.7

15.1 ± 3.6

0.592

Marital status

Single

5 (13.5)

7 (19.4)

0.543

Married

27 (73.0)

22 (61.1)

0.326

Divorced

3 (8.1)

6 (16.7)

0.308

Widowed

2 (5.4)

1 (2.8)

1.000

Number of children

2.5 ± 1.4

2.4 ± 1.5

0.839

Employment status

Full time

24 (64.9)

22 (61.1)

0.811

Part time

9 (24.3)

11 (30.6)

0.607

Not employed

4 (10.8)

3 (8.3)

1.000

Time from infection (days)

159.1 ± 71.3

171.5 ± 66.4

0.450

Hospitalized*

4 (10.8)

8 (22.2)

0.221

MoCA—cognitive assessment

25.4 ± 3.6

25.0 ± 3.3

0.601

High risk conditions

BMI > 30

11 (29.7)

9 (25.0)

0.794

Age > 60 years

4 (10.8)

4 (11.1)

1.000

Cancer

0 (0.0)

0 (0.0)

1.000

Diabetes mellitus

1 (2.7)

1 (2.8)

1.000

Hypertension

4 (10.8)

2 (5.6)

0.674

Heart disease

1 (2.7)

1 (2.8)

1.000

Immune deficiency

0 (0.0)

0 (0.0)

1.000

Asthma

2 (5.4)

1 (2.8)

1.000

Other chronic lung diseases

0 (0.0)

0 (0.0)

1.000

Chronic liver disease

0 (0.0)

4 (11.1)

0.054

Chronic kidney disease

0 (0.0)

0 (0.0)

1.000

Hematologic disease\disorder

0 (0.0)

0 (0.0)

1.000

Chronic neurological impairment\disease

1 (2.7)

1 (2.8)

1.000

Smoking

Current

0 (0.0)

0 (0.0)

1.000

Previous

10 (27.0)

7 (19.4)

0.581

  1. Data presented as n (%); continuous data, mean ± SD; The body-mass index is the weight in kilograms divided by the square of the height in meters. *During COVID-19 infection. MoCA Montreal Cognitive Assessment.